Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4D Trial: Dexmedetomidine for Delirium in Non-intubated ICU Patients
NCT03317067Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in delirium, agitation, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Dec 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
deliriumagitation
Beyond the preview
Go deeper on NCT03317067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317067.